| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/07/2009 | CN101548952A Anisodamine dry powder inhalation, preparation method and application thereof |
| 10/07/2009 | CN101548951A Hydroxycamptothecin nano lipidosome for injections and method for preparing same |
| 10/07/2009 | CN101548950A Tripterine nanometer lipid injection and method for preparing same |
| 10/07/2009 | CN101548949A Paclitaxel nanoemulsion injection |
| 10/07/2009 | CN101548947A Docetaxel nanometer lipid injection, preparation method and purpose thereof |
| 10/07/2009 | CN101548946A Curcumin nano-lipid injection liquid, preparation method and application thereof |
| 10/07/2009 | CN101548945A Long-acting flunixin meglumine injection and method for preparing same |
| 10/07/2009 | CN101548944A Pharmaceutical composition containing enoximone and preparation method thereof |
| 10/07/2009 | CN101548943A Inhalation nebulizer containing formoterol |
| 10/07/2009 | CN101548942A Oral solid pharmaceutical composition containing clinofibrate |
| 10/07/2009 | CN101548683A Liquid disinfectant and method of producing the same |
| 10/07/2009 | CN100547075C Her-2/neu DNA vaccine having anti-cancer activity |
| 10/07/2009 | CN100547071C Antisense antiviral agent and method for treating ssRNA viral infection |
| 10/07/2009 | CN100546999C Bindwood sapogenin and its preparation method and use |
| 10/07/2009 | CN100546985C Febuxotat microcrystal and compositions thereof |
| 10/07/2009 | CN100546980C Benzimidazole derivates: preparation and pharmaceutical applications |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546976C Nitroaniline-based alkylating agents and their use as prodrugs |
| 10/07/2009 | CN100546657C Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 10/07/2009 | CN100546656C Kidney-targeted medicine vector and the formed prodrug, preparation method and uses |
| 10/07/2009 | CN100546653C Time selecting released preparation containing angiotensin II 1 receptor antagonist |
| 10/07/2009 | CN100546644C Externally applied Chinese medicine lotion for treating pain caused by wind, cold and damp |
| 10/07/2009 | CN100546637C Chinese medicinal composition for treating coronary heart disease and preparation thereof |
| 10/07/2009 | CN100546636C Medicine for treating cervical erosion and preparing method thereof |
| 10/07/2009 | CN100546626C Medicine for treating coronary heart disease, hyperlipidemia and senility resistance, and its preparation method |
| 10/07/2009 | CN100546622C A multi-element balanced health product |
| 10/07/2009 | CN100546610C Medicine and food dual purpose product for preventing myopia and its manufacturing method |
| 10/07/2009 | CN100546606C Medicine for preventing and treating fowl's respiratory tract diseases and preparing method |
| 10/07/2009 | CN100546605C A medicinal composition for treating viral infection of upper respiratory tract and its preparation method |
| 10/07/2009 | CN100546604C Foaming medicine for vaginitis and cervical erosion and its preparation method |
| 10/07/2009 | CN100546587C Medicine and food dual purpose compound vitamin and compound microelement nutritive product for preventing and treating xeroma and its manufacturing method |
| 10/07/2009 | CN100546586C Application of yew amylose in pharmacy |
| 10/07/2009 | CN100546585C Compound puerarin injection and preparation method thereof |
| 10/07/2009 | CN100546584C Novel medicinal uses of icariin |
| 10/07/2009 | CN100546583C Use of rhizoma anemarrhenae total saponin in preparation of medicine for treating hyperlipemia and arterial sclerosis |
| 10/07/2009 | CN100546582C Novel compound calcium replenishing tablet |
| 10/07/2009 | CN100546581C Combinations comprising anti-epileptic drugs for the treatment of neurological disorders. |
| 10/07/2009 | CN100546580C Nicotin or isonicotin benzothiazole derivatives |
| 10/07/2009 | CN100546579C Nanometer microsphere of temozolomide polylactic acid and its preparation and preparing method therefor |
| 10/07/2009 | CN100546578C Anticancer medicine composition and its application in preparing anticancer medicine |
| 10/07/2009 | CN100546577C Medical use for silybum or its salt |
| 10/07/2009 | CN100546576C Application of derivative of hesperetin as anti-inflammatory and immune medicine |
| 10/07/2009 | CN100546575C Medicine composition containing red clover prime and prunetin and its medicinal application |
| 10/07/2009 | CN100546574C Injectable liquid formulation of paracetamol |
| 10/07/2009 | CN100546573C Anti-infection medicinal composition and its preparing method |
| 10/07/2009 | CN100546572C Hydrochloride clindamycin palmitate soft capsule and the preparing method thereof |
| 10/07/2009 | CN100546568C Pharmaceutical composition comprising pimobendan |
| 10/06/2009 | US7598419 Such as N-(Cyanoacetyl)-3,4-dimethoxybenzylamide |
| 10/06/2009 | US7598418 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction |
| 10/06/2009 | US7598417 Analgesics; muscular disorders; diarrhea |
| 10/06/2009 | US7598416 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 10/06/2009 | US7598412 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators |
| 10/06/2009 | US7598398 Acyl indoles, compositions containing such compounds and methods of use |
| 10/06/2009 | US7598396 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; improves performance characteristics of pharmaceutical product |
| 10/06/2009 | US7598394 Made by reacting a cyano compound with a silylalkylisocyanide compound; silylimidazole ; |
| 10/06/2009 | US7598393 Sulfonyl benzimidazole derivatives |
| 10/06/2009 | US7598392 1-(1,5-dimethyl-1H-pyrazole-3-carbonyl)piperidine-3-carboxylic acid [4-(5-cyclohexyl-2-methoxyphenyl)thiazol-2-yl]amide; chemokine receptor modulators |
| 10/06/2009 | US7598391 Heteroaryl-ureas and their use as glucokinase activators |
| 10/06/2009 | US7598386 Sulphones which modulate the action of gamma-secretase |
| 10/06/2009 | US7598384 Specific binding is extremely high; low toxicity; high degree of activity; 2-(5-m-Tolyl-thiazol-2-yl )-7,8-dihydro-6H-quinolin-5-one, acute and/or chronic neurological disorders |
| 10/06/2009 | US7598383 mitogen activated protein kinase inhibitors; 4-(2-fluoro-4-methylphenylamino)-1,3-dimethyl-6,7-dihydro-1H-pyrrolo[3,4-b]pyridine-2,5-dione; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals |
| 10/06/2009 | US7598377 (+-)-7-Methyl-2-morpholin-4-yl-9-(1-phenylaminoethyl)-pyrido[1,2-a]pyrimidin-4-one, for example; selective inhibitors of phosphoinositide (PI) 3-kinase beta for use in anti-thrombotic therapy |
| 10/06/2009 | US7598373 Process for the production of 2-C-methyl-D-ribonolactone |
| 10/06/2009 | US7598370 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA |
| 10/06/2009 | US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/06/2009 | US7598318 reacting poly(ethylene glycol) or its sodium salt and the poly(dichlorophosphazene), reacting the product formed with an oligopeptideester or its acid salt |
| 10/06/2009 | US7598294 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598292 such as {2-Methyl-4-[2-(4-trifluoromethyl-phenoxymethyl )-allylsulfanyl]-phenoxy}-acetic acid, used as peroxisome proliferator-activated receptors modulators for treating or inhibit the progression of dyslipidemia |
| 10/06/2009 | US7598291 Methods and compositions for enhancing collagen and proteoglycan synthesis in the skin |
| 10/06/2009 | US7598290 Cytotoxic agents comprising new C-2 modified taxanes |
| 10/06/2009 | US7598289 Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions |
| 10/06/2009 | US7598288 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 10/06/2009 | US7598287 Anticancer agents; infection; immunosuppressants |
| 10/06/2009 | US7598286 (1-Cyclopentyl-1H-indazol-3-yl)(3-hydroxyphenyl)methanone, for example; antiinflammatory agents for treatment of rheumatoid arthritis, spondyloarthropathies, inflammatory bowel disease, Crohn's disease, ulcerative colitis, psoriasis, asthma, without stimulating uterine and breast cell proliferation |
| 10/06/2009 | US7598285 N-[4-((1S)-1-{3-(3,5-Dichlorophenyl)-5-[6-(trifluoromethoxy)-2-naphthyl]-1H-pyrazol-1-yl}ethyl)benzoyl]- beta -alanine; type 2 diabetes, hyperglycemia, or insulin resistance |
| 10/06/2009 | US7598284 Indazole compounds as B3 adrenoceptor agonist |
| 10/06/2009 | US7598283 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
| 10/06/2009 | US7598282 (3R,5S,7as)-(3,5-bis(4-fluorophenyl)tetrahydro-1H-oxazolo[3,4-c]oxazol-7a-yl)methanol; does not involve microtubule stabilization; Alzheimer's |
| 10/06/2009 | US7598281 2-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxymethyl)cyclohexylcarbamoyl]cyclobutanecarboxylic acid; modulation and control lipid and/or carbohydrate metabolism |
| 10/06/2009 | US7598280 For the treatment, prevention and management of inflammatory and autoimmune diseases and disorders; for example, (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol |
| 10/06/2009 | US7598279 Neurotherapeutic azole compounds |
| 10/06/2009 | US7598278 Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss |
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598276 Pharmaceutical salts and polymorphs of a factor Xa inhibitor |
| 10/06/2009 | US7598275 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 10/06/2009 | US7598274 Pyrrole derivatives |
| 10/06/2009 | US7598273 Inhibitors of the gastric H+, K+-ATPase with enhanced therapeutic properties |
| 10/06/2009 | US7598272 Kinase inhibitors |
| 10/06/2009 | US7598271 Crystalline paroxetine methane sulfonate |
| 10/06/2009 | US7598270 Diagnostic agent for detecting colorectal carcinoma by detecting presence of HERG potassium channel in tissue biopsy of human colon or rectum or in lymph nodes, which are free of HERG potassium channels in healthy human; 4-[1-[2-(6-methyl-2-pyridinyl)ethyl-4-piperidin-yl]carbonyl]methanesulfoanilide |
| 10/06/2009 | US7598269 3-(4-phenyl-1,2,3,6-tetrahydropyridin-1-yl)-1-propanesulfonic acid; reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 10/06/2009 | US7598268 Vascular endothelial growth factor; tyrosine kinase inhibitor;angiogenesis inhibitor; anticarcinogenic agents |
| 10/06/2009 | US7598266 Fused heterocyclic derivatives as PPAR modulators |
| 10/06/2009 | US7598265 Compositions and methods for treating CNS disorders |
| 10/06/2009 | US7598264 HIV integrase inhibitors |
| 10/06/2009 | US7598263 9-[(3-hydroxy-5-methoxyphenyl)amino]-1,2-dihydrothieno[3,2-f]quinoline-8-carbonitrile 3,3-dioxide; protein tyrosine kinases inhibitor, especially erythropoetin-producing hepatoma amplified sequence (Eph) receptors antagonist; antitumor, angiogenesis inhibitor, neurodegenerative diseases |
| 10/06/2009 | US7598262 Method for treating diabetes |
| 10/06/2009 | US7598261 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other delta opioid receptor-mediated conditions; minimized undesirable side effects |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |